Circular RNA CircTP63 Enhances Estrogen Receptor-positive Breast Cancer Progression and Malignant Behaviors Through the MiR-873-3p/FOXM1 Axis
Overview
Authors
Affiliations
Circular RNAs (circRNAs) have been shown to play a functional role in a variety of cancers. However, few studies on circRNAs in estrogen receptor-positive breast cancer have been conducted. Here, we investigated the role of circRNA circTP63 in estrogen receptor-positive breast cancer progression and malignant behaviors. First, we observed increased expression of circTP63 in MCF7 cells relative to normal human mammary epithelial cell lines, such as DU4475 and MCF-10A, and the changed oncogenicity of MCF7 cells correlated with circTP63 overexpression and downregulation. Interestingly, a series of gain- and loss-of-function assays revealed that a higher level of FOXM1 was closely associated with MCF7 malignant behaviors induced by circTP63 overexpression. Further investigations showed that circTP63 sponged to miR-873-3p, which targeted FOXM1 mRNA and inhibited its expression. Mechanistically, circTP63 binds to miR-873-3p and prevents the targeting of FOXM1, thus inducing the progression and malignant behaviors of estrogen receptor-positive breast cancer, such as cell proliferation, cell cycle dysregulation, invasion, migration and even tumor growth. CircTP63 might be a potential biomarker or target to treat estrogen receptor-positive breast cancer patients in the future.
Wang D, Zuo S, Ge J, Qu H, Wu J, Yi N Sci China Life Sci. 2025; 68(3):689-705.
PMID: 39754006 DOI: 10.1007/s11427-023-2737-2.
circTP63 promotes prostate cancer progression via miR-421/VAMP associated protein A axis.
Xu J, Xu S, Liu W, Chen J, Cai L, Zhuang W J Cancer. 2024; 15(16):5451-5461.
PMID: 39247600 PMC: 11375539. DOI: 10.7150/jca.99561.
Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer.
Zhu J, Li Q, Wu Z, Xu W, Jiang R Noncoding RNA Res. 2024; 9(1):262-276.
PMID: 38282696 PMC: 10818160. DOI: 10.1016/j.ncrna.2023.12.005.
Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
Qiu X, Chen Y, Zhu X, Gong Z, Yu F, Zhang P Asian Pac J Cancer Prev. 2023; 24(4):1275-1287.
PMID: 37116150 PMC: 10352730. DOI: 10.31557/APJCP.2023.24.4.1275.
Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.
Treeck O, Haerteis S, Ortmann O Cancers (Basel). 2023; 15(6).
PMID: 36980520 PMC: 10046587. DOI: 10.3390/cancers15061632.